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Pharmacotherapy is commonly applied to stroke patients to
prevent complications or enhance recovery. The aim of post
stroke recovery treatments is to enhance structural and func-
tional reorganization of the brain. The mechanism underlying
CNS plasticity include unmasking of latent connections, ax-
onal sprouting and synaptogenesis. Medications may boost that
process and enable a patients to more actively contribute to the
rehabilitation. Most clinical studies focus on interventions in-
volving neurotransmitter modulation and aim to activate all
areas that are functionally linked with the lesioned  structures.
Drugs that blocked the reuptake of selective serotonin re-up-
take(SSRI) caused increased activation of the motor cortex in
healthy individuals during exercise. Several small clinical stud-
ies with SSRIs demonstrated clinical benefit on post stroke
motor recovery. Most studies were done with fluoxetine. Meta-
analysis  showed positive effect of fluoxetine on disability at the
end of treatment, however there was substantial heterogeneity
among trials. There are few  ongoing randomized trials  which
should give provide evidence to support ( or refute) the routine
use of SSRI for patients early after stroke. 
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